0001104659-19-031861.txt : 20190524 0001104659-19-031861.hdr.sgml : 20190524 20190524215800 ACCESSION NUMBER: 0001104659-19-031861 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190424 FILED AS OF DATE: 20190524 DATE AS OF CHANGE: 20190524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schlesinger Sarah J. CENTRAL INDEX KEY: 0001579873 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 19855836 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Innoviva, Inc. CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 6502389600 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: THERAVANCE INC DATE OF NAME CHANGE: 20020207 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 a4.xml 4 X0306 4 2019-04-24 0 0001080014 Innoviva, Inc. INVA 0001579873 Schlesinger Sarah J. 2000 SIERRA POINT PARKWAY, SUITE 500 BRISBANE CA 94005 1 0 0 0 Common Stock 2019-04-24 4 A 0 16399 0 A 41165 D The Reporting Person was granted restricted stock units ("RSUs"). 100% of the RSUs will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date. /s/ Sarah J. Schlesinger 2019-05-24